Wall Street Analysts See a 60.61% Upside in Amicus Therapeutics (FOLD): Can the Stock Really Move This High?Zacks Investment Research • 12/12/25
Surging Earnings Estimates Signal Upside for Amicus Therapeutics (FOLD) StockZacks Investment Research • 12/05/25
Amicus Therapeutics (FOLD) Up 6.4% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 12/04/25
Wall Street Analysts Think Amicus Therapeutics (FOLD) Could Surge 58.46%: Read This Before Placing a BetZacks Investment Research • 11/26/25
Amicus Therapeutics, Inc. (FOLD) Presents at UBS Global Healthcare Conference 2025 TranscriptSeeking Alpha • 11/10/25
Wall Street Analysts Believe Amicus Therapeutics (FOLD) Could Rally 76.32%: Here's is How to TradeZacks Investment Research • 11/10/25
Amicus' Q3 Earnings Beat, Higher Product Sales Drive Y/Y RevenuesZacks Investment Research • 11/05/25
Compared to Estimates, Amicus Therapeutics (FOLD) Q3 Earnings: A Look at Key MetricsZacks Investment Research • 11/05/25
Amicus Therapeutics (FOLD) Beats Q3 Earnings and Revenue EstimatesZacks Investment Research • 11/04/25
Amicus Therapeutics Announces Third Quarter 2025 Financial Results and Corporate UpdatesGlobeNewsWire • 11/04/25
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025GlobeNewsWire • 10/31/25
Amicus Therapeutics to Announce Third Quarter 2025 Financial Results on November 4, 2025GlobeNewsWire • 10/23/25
Amicus Therapeutics: Turning The Corner To Profitability With 2 Developing TherapiesSeeking Alpha • 10/23/25
All You Need to Know About Amicus Therapeutics (FOLD) Rating Upgrade to Strong BuyZacks Investment Research • 10/07/25
Bet on These 3 Stocks With Upgraded Broker Ratings for Solid ReturnsZacks Investment Research • 10/06/25
RIGL vs. FOLD: Which Biotech Stock Offers Better Growth Potential?Zacks Investment Research • 09/25/25
Strength Seen in Amicus Therapeutics (FOLD): Can Its 6.4% Jump Turn into More Strength?Zacks Investment Research • 09/19/25
Amicus Therapeutics, Inc. (FOLD) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)Seeking Alpha • 09/09/25
New 4-Year Data for Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Presented at ICIEMGlobeNewsWire • 09/08/25